Toripalimab With Paclitaxel and Cisplatin as Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma
Condition(s):Esophageal Squamous Cell CancerLast Updated:February 1, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Esophageal Squamous Cell CancerLast Updated:February 1, 2023Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:January 22, 2024Not yet recruiting
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:February 2, 2024Completed
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:March 4, 2024Terminated
Condition(s):Squamous Cell Carcinoma of the Head and NeckLast Updated:February 25, 2019Terminated
Condition(s):Laryngeal Squamous Cell CarcinomaLast Updated:April 27, 2023Not yet recruiting
Condition(s):Hend and Neck Squamous Cell Carcinoma Locally Advanced OperableLast Updated:November 22, 2023Not yet recruiting
Condition(s):Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCCLast Updated:February 17, 2023Active, not recruiting
Condition(s):Locally Advanced Esophageal Squamous Cell CarcinomaLast Updated:August 23, 2021Unknown status
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:February 16, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.